Structure and Function of Voltage-Gated Ion Channels and their Applications for Rational Drug Design
Lead Research Organisation:
Birkbeck, University of London
Department Name: Biological Sciences
Abstract
Sodium channels are membrane proteins which enable the regulation and flow of sodium ions across cell membranes. They are found in all eukaryotic organisms and a range of bacteria. In humans they exhibit a wide range of functions in the healthy organism, and are the targets for many pharmaceutical drugs for treatment of neurological and cardiac diseases. In insects they are the target sites of many insecticides, and also the source of development of resistance. This proposal is to determine the crystal structures of a number of natural and mutant sodium channels and related ion channels, and compare their structures with functional studies to better understand the means by which the channels open and close and selectively translocate sodium ions. By examining complexes of these channels with actual and potential drugs and ligands, this should enhance the rational development of new and highly specific insecticides and pharmaceuticals.
Technical Summary
Voltage-gated sodium channels are responsible for transmembrane sodium ion conduction and, in eukaryotes, for electrical signalling in excitable cells. Their opening represents the first step in the action potential and they are key targets for the development of pharmaceutical drugs as well as novel and specific insecticides and mitocides. Sodium channels are also present in a wide range of prokaryotes, where they have roles in motility and chemotaxis. Related voltage-gates ion channels with different selectivity profiles are also found across the eukaryotics/prokaryotic spectrum and include roles such in diverse functions as fertilisation and sensation. This proposal aims to use a range of molecular biology, crystallographic, biophysical and electrophysiological techniques to define the structure and molecular bases of their gating, selectivity and drug/ligand interactions, to enhance our understanding the molecular basis of insecticide resistance, and to aid in the rational design of highly specific pharmaceuticals.
Planned Impact
The potential public and economic impacts of this research are manifold, because sodium and other ion channels are essential components in human health and in agriculture. The beneficiaries will include both the commercial private sector, especially the pharmaceutical and agricultural industries (and hence the economy) and the public (by enhancing quality of life and productivity).
Impact on the Economy:
The pharmaceutical market for specific and highly efficacious sodium channel inhibitors/modulators is enormous, because the potential number of people with either chronic or acute pain is vast. It is for this reason that big pharma companies, as well as many smaller biotech companies have active programmes for the development of sodium channel-targeting drugs. The availability of the structures of crystalline complexes of sodium channels with ligands whose activity profiles have been defined in parallel with the structural studies, should have a dramatic impact on the initial and refinement phases of new drug design. Furthermore, the plethora of diseases (epilepsy, heart disease, myotonia, etc.) related to sodium channel misfunctioning in other tissues means that drug company development programmes in these areas should also benefit from the availability of drug/channel complex structures, especially as they should enable comparative modelling studies of homologous isoforms to better enable specific targeting for treatments without side effects resulting from broad-based sodium channel inhibitors.
There is also a very considerable market for species-specific insecticides and mitocides. Sodium channels are the targets for the pyrethroid compounds currently on the market, and were the targets of DDT, which ultimately produced significant resistance in the field. Knowledge of the binding site interactions for both of these types of compounds and for other new insecticides in development should enable the development of more specific insecticides/mitocides and ones that may be less likely to development resistance, both features of which could be important economically for the commercial sector.
Impact on the Public:
An essential aspect of "quality of life" is the ability to live pain-free. Sodium channels are causally associated with pain perception in humans and are currently the targets of a number of marketed pharmaceuticals. The availability of a sodium channel/drug complex structure should have a major impact on the design and development of new drugs to treat pain, and hence directly on the quality of life of the general public. The development of new and more specific drugs to treat neurological diseases such as epilepsy and various cardiovascular diseases will also benefit significant segments of the population.
In addition, the ability to more efficiently produce crops not destroyed by insects, but with more specifically targeted insecticides that do not harm either humans or plants, would also have a major quality of life factor in the ability to produce crops more effectively without harmful side effects to farmers and the environment.
Impact on the Economy:
The pharmaceutical market for specific and highly efficacious sodium channel inhibitors/modulators is enormous, because the potential number of people with either chronic or acute pain is vast. It is for this reason that big pharma companies, as well as many smaller biotech companies have active programmes for the development of sodium channel-targeting drugs. The availability of the structures of crystalline complexes of sodium channels with ligands whose activity profiles have been defined in parallel with the structural studies, should have a dramatic impact on the initial and refinement phases of new drug design. Furthermore, the plethora of diseases (epilepsy, heart disease, myotonia, etc.) related to sodium channel misfunctioning in other tissues means that drug company development programmes in these areas should also benefit from the availability of drug/channel complex structures, especially as they should enable comparative modelling studies of homologous isoforms to better enable specific targeting for treatments without side effects resulting from broad-based sodium channel inhibitors.
There is also a very considerable market for species-specific insecticides and mitocides. Sodium channels are the targets for the pyrethroid compounds currently on the market, and were the targets of DDT, which ultimately produced significant resistance in the field. Knowledge of the binding site interactions for both of these types of compounds and for other new insecticides in development should enable the development of more specific insecticides/mitocides and ones that may be less likely to development resistance, both features of which could be important economically for the commercial sector.
Impact on the Public:
An essential aspect of "quality of life" is the ability to live pain-free. Sodium channels are causally associated with pain perception in humans and are currently the targets of a number of marketed pharmaceuticals. The availability of a sodium channel/drug complex structure should have a major impact on the design and development of new drugs to treat pain, and hence directly on the quality of life of the general public. The development of new and more specific drugs to treat neurological diseases such as epilepsy and various cardiovascular diseases will also benefit significant segments of the population.
In addition, the ability to more efficiently produce crops not destroyed by insects, but with more specifically targeted insecticides that do not harm either humans or plants, would also have a major quality of life factor in the ability to produce crops more effectively without harmful side effects to farmers and the environment.
Publications
Amey JS
(2015)
An evolutionarily-unique heterodimeric voltage-gated cation channel found in aphids.
in FEBS letters
Bagnéris C
(2015)
Structural model of the open-closed-inactivated cycle of prokaryotic voltage-gated sodium channels.
in The Journal of general physiology
Bagnéris C
(2014)
Prokaryotic NavMs channel as a structural and functional model for eukaryotic sodium channel antagonism.
in Proceedings of the National Academy of Sciences of the United States of America
Colledge M
(2017)
AnglerFish: a webserver for defining the geometry of a-helices in membrane proteins.
in Bioinformatics (Oxford, England)
Field LM
(2017)
Voltage-gated sodium channels as targets for pyrethroid insecticides.
in European biophysics journal : EBJ
Hollingworth D
(2022)
Tamoxifen complexes with the voltage-gated sodium channel reveal novel drug binding sites
in Biophysical Journal
Ke S
(2018)
Role of the Interaction Motif in Maintaining the Open Gate of an Open Sodium Channel.
in Biophysical journal
Ke Song
(2016)
Molecular Dynamics Simulations of the Open State Structure of a Bacterial Voltage-Gated Sodium Channel Reveal the Binding Mechanisms of Channel Blockers
in BIOPHYSICAL JOURNAL
Liko I
(2018)
Lipid binding attenuates channel closure of the outer membrane protein OmpF.
in Proceedings of the National Academy of Sciences of the United States of America
Title | advisor to national dance company on science-related performances for the public [continuing] |
Description | "Stilled" performances at the Royal Festival Hall and Wellcome Collection based on crystallography - i was scientific advisor |
Type Of Art | Performance (Music, Dance, Drama, etc) |
Year Produced | 2011 |
Impact | contacts from other artists interested in science/art collaborations and contacts from the general public about performance. note that this is an ongoing activity |
Description | Development of methods and materials enabling structure determination of voltage-gated sodium channels |
Exploitation Route | This work was followed on by grant BB/R001294/1 |
Sectors | Agriculture Food and Drink Pharmaceuticals and Medical Biotechnology |
Description | used by Pfizer Neusentis and several other drug companies as knowledge base for drug development |
First Year Of Impact | 2014 |
Sector | Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology |
Impact Types | Economic |
Description | BBSRC responsive mode grant |
Amount | £744,552 (GBP) |
Funding ID | BB/R01294 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 09/2017 |
End | 09/2021 |
Description | MRC CASE studentship |
Amount | £21,200 (GBP) |
Organisation | Pfizer Ltd |
Department | Neusentis Pfizer |
Sector | Private |
Country | United Kingdom |
Start | 09/2013 |
End | 09/2017 |
Description | MRC cASE studentship |
Amount | £1 (GBP) |
Organisation | Pfizer Ltd |
Department | Neusentis Pfizer |
Sector | Private |
Country | United Kingdom |
Start | 09/2014 |
End | 09/2018 |
Description | NIH grant (with Prof Hugh Hemmings - Cornell Medical School) |
Amount | £30,683 (GBP) |
Funding ID | GM058055 |
Organisation | National Institutes of Health (NIH) |
Sector | Public |
Country | United States |
Start | 04/2016 |
End | 04/2019 |
Description | Pfizer Neusentis funding |
Amount | £20,000 (GBP) |
Organisation | Pfizer Ltd |
Department | Neusentis Pfizer |
Sector | Private |
Country | United Kingdom |
Start | 05/2014 |
End | 01/2015 |
Description | Science without Borders Visiting Researcher |
Amount | R$ 11,524,000 (BRL) |
Organisation | National Council for Scientific and Technological Development (CNPq) |
Sector | Public |
Country | Brazil |
Start | 03/2014 |
End | 02/2016 |
Description | Science without Borders psotdoctoral fellowships (3) |
Amount | R$ 1 (BRL) |
Organisation | National Council for Scientific and Technological Development (CNPq) |
Sector | Public |
Country | Brazil |
Start | 08/2012 |
End | 01/2016 |
Description | UK/U Partnering |
Amount | £42,000 (GBP) |
Funding ID | L004976 |
Organisation | Biotechnology and Biological Sciences Research Council (BBSRC) |
Sector | Public |
Country | United Kingdom |
Start | 04/2014 |
End | 04/2018 |
Title | oriented circular dichroism spectroscopy - methods development and software analysis tools |
Description | development of methodology and software analysis tools for oriented CD spectroscopy |
Type Of Material | Improvements to research infrastructure |
Year Produced | 2017 |
Provided To Others? | Yes |
Impact | other research groups interested in/using our Anglerfish server |
URL | http://anglerfish.cryst.bbk.ac.uk/ |
Title | depostion of new crystal structure entries into the protein data bank (PDB) |
Description | The PDB is the international standard data base for the deposition of crystal structures and the many crystal structures produced during this grant have been deposited for public access |
Type Of Material | Database/Collection of data |
Year Produced | 2022 |
Provided To Others? | Yes |
Impact | increased understanding of drug interactions (including off-target interations of currently marketed drugs) |
Description | collaboration on general anaethetics |
Organisation | Cornell University |
Department | Weill Cornell Medicine |
Country | United States |
Sector | Academic/University |
PI Contribution | structural studies on general anaethetics and ion channels |
Collaborator Contribution | electrophysiological studies on general anaethetics and ion channels |
Impact | ongoing studies still in progress |
Start Year | 2015 |
Description | collaboration on molecular dynamics and structural studies |
Organisation | Johns Hopkins University |
Country | United States |
Sector | Academic/University |
PI Contribution | structural studies (spectroscopic and crystallographic) |
Collaborator Contribution | molecular dynamics calculations |
Impact | joint publications and talks at meetings |
Start Year | 2010 |
Description | collaboration with Pfizer |
Organisation | Pfizer Ltd |
Department | Neusentis Pfizer |
Country | United Kingdom |
Sector | Private |
PI Contribution | crystal structures and functional studies of sodium channel/drug complexes |
Collaborator Contribution | provided 0.5 funding for one year for postdoc and compounds for characterisation |
Impact | publications (see list) |
Start Year | 2014 |
Description | School visit (Tonbridge schools science day) |
Form Of Engagement Activity | Participation in an open day or visit at my research institution |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Schools |
Results and Impact | Keynote speaker and poster judge at Tonbridge Area Schools Science day |
Year(s) Of Engagement Activity | 2019 |
Description | Talks at UK and international sites and meetings: Brazil Synchrotron Symposium, ), University of Vienna Austria (Chemistry Dept), Biochemical Society Training Course (Aston University, UK) |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Talks about Tools and Resources developed in the course of this grant at Universities and International meetings, including the headline talk at the inauguration of the Brazil Synchrotron SRCD beamline (CEDRO) held for the international community of SRCD users and potential users, The Biochemical Society training course on Membrane Proteins at Aston University, the chemistry dept at the University of Vienna. |
Year(s) Of Engagement Activity | 2022 |
Description | annual talks for the public |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | UCL Science Centre Friday Evening Discourses and Birkbeck SET Talks for the Public talks on science for the public (5th, 6th form, and public) annually and lecture/tour at the Wellcome Collection talks no actual impacts realised to date |
Year(s) Of Engagement Activity | 2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016,2017,2018,2019,2020,2021 |
Description | crystallography and culture |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | technical advisor for development of dance performances and "in residence" talks for the public on women in crystallography the opera is the basis for funding applications to arts agencies |
Year(s) Of Engagement Activity | 2014 |
URL | https://www.youtube.com/watch?v=8d0rpEdCTac |
Description | international advisory board (australia) |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Postgraduate students |
Results and Impact | international advisory board for scientific centre of excellence (australia) |
Year(s) Of Engagement Activity | 2008,2009,2010,2011,2012,2013,2014,2015,2016,2017 |
Description | talk to 5th/6th form students and the general public on 100 years of crystallography |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | Yes |
Geographic Reach | Regional |
Primary Audience | Schools |
Results and Impact | talk to public and 5th/6th formers students expressed interest in science |
Year(s) Of Engagement Activity | 2014 |